文献速递颅颌面外科

预防性抗生素与原发性腭成形术后瘘孔率的关系

The Use of Prophylactic Antibiotics before Primary Palatoplasty Is Not Associated with Lower Fistula Rates: An Outcome Study Using the Pediatric Health Information System Database.
PubMed 文献 · Plast Reconstr Surg · 2019-01-01

结果显示术前抗生素组瘘孔率为5.9%,多因素分析中术前抗生素与未用抗生素相比OR为0.88(95%CI 0.59–1.31),差异无统计学意义。

要点

  • 术前预防性抗生素未显著降低原发性腭成形术后口鼻瘘修补的 odds(OR 0.88,95%CI 0.59–1.31)。
  • 证据等级为治疗性 III 级,支持术前抗生素并非常规必要措施。

核心结论

  • 术前给予抗生素与未用抗生素相比,后续口鼻瘘修补的 odds 无显著统计学差异(OR 0.88;95%CI 0.59–1.31)。
  • 研究结论认为术前抗生素未显著降低同一 PHIS 机构内原发性腭成形术后的瘘孔修补 odds。

研究设计与样本

  • 基于儿科健康信息系统(PHIS)数据库的回顾性结局研究。
  • 通过 ICD-9 手术代码21.82 识别2004至2015年间后续口鼻瘘修补,药房计费记录判定抗生素使用。
  • 采用随机截距 logistic 回归校正年龄、性别、种族和腭裂类型。

主要发现

  • 术前抗生素组、仅术后抗生素组和未用抗生素组的瘘孔率分别为5.9%、11.4%和5.2%(p < 0.001)。
  • 多因素分析中术前抗生素组与未用抗生素组的口鼻瘘 odds 无显著统计学差异(OR 0.88;95%CI 0.59–1.31)。

关键数值与推荐

  • 瘘孔率:术前抗生素组5.9%,仅术后抗生素组11.4%,未用抗生素组5.2%(p < 0.001)。
  • 校正后 OR 0.88(95%CI 0.59–1.31),术前抗生素与未用抗生素无显著差异。
  • 证据等级:治疗性,III 级。

临床怎么用

  • 原发性腭成形术围手术期不应仅以降低瘘孔率为目的常规给予术前预防性抗生素。
  • 术后抗生素使用与更高瘘孔率相关,需结合感染风险个体化评估而非为防瘘常规使用。

局限性

  • 为回顾性数据库研究,抗生素使用依据药房计费记录判定,可能存在暴露错分。
  • 瘘孔仅通过后续修补手术代码识别,可能低估未修补或延迟修补的瘘孔。
  • 证据等级为 III 级,无法排除未测量混杂因素的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Previous attempts to study the effect of prophylactic antibiotics on the outcomes of cleft palate surgery have been hampered by the need for a very large sample size to provide adequate power to discern a potentially small therapeutic effect. This limitation can be overcome by querying large databases created by health care governing bodies. METHODS: Data from the Pediatric Health Information System database were used for this analysis. Patients, aged 6 to 18 months, who had undergone primary palatoplasty (International Classification of Diseases, Ninth Revision, code 27.62) between 2004 and 2009 were included. Subsequent repair of an oronasal fistula between 2004 and 2015 was identified by International Classification of Diseases, Ninth Revision, procedure code 21.82. Pharmacy billing records were used to determine antibiotic administration. Associations between antibiotic administration and fistula repair were assessed using random-intercept logistic regression adjusting for age, sex, race, and cleft type. RESULTS: Seven thousand one hundred sixty patients were available for analysis; of these, 460 (6.4 percent) had a subsequent repair of an oronasal fistula. Fistula rates were 5.9, 11.4, and 5.2 percent among patients given preoperative antibiotics, only postoperative antibiotics, and no antibiotics, respectively (p < 0.001). Multivariable analysis results showed that the odds of having an oronasal fistula among patients who were administered preoperative antibiotics did not differ significantly (statistically) from patients who did not receive antibiotics (OR, 0.88; 95 percent CI, 0.59 to 1.31). CONCLUSIONS: The treatment goal of primary palatoplasty is the successful repair of the cleft without an oronasal fistula. Administration of preoperative antibiotics did not significantly reduce the odds of subsequent fistula repair within the same Pediatric Health Information System institution following primary palatoplasty. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, III.

来源:Plast Reconstr Surg,查看原文。版权归原作者所有。

引用

  1. Jodeh DS, Nguyen ATH, Cray JJ, et al. The Use of Prophylactic Antibiotics before Primary Palatoplasty Is Not Associated with Lower Fistula Rates: An Outcome Study Using the Pediatric Health Information System Database. Plast Reconstr Surg. 2019. PMID: 31348354. doi:10.1097/PRS.0000000000005843

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。